Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- VDR conformational ensemble
- Receptor ligand interactions
- A vitamin D receptor ensemble model
- VDR-1,25(OH)2D3 (G-pocket) complex
- A modeling surprise: two pockets found
- Summary: 1,25(OH)2D3 VDR G- and A-pockets
- Summary of rapid responses
- Vitamin D nutrition for good health
- Where do we obtain vitamin D?
- How much vitamin D do we need?
- What is the RDA for vitamin D?
- How do we obtain our vitamin D RDA? (1)
- How do we obtain our vitamin D RDA? (2)
- How do we obtain our vitamin D RDA? (3)
- Skin cancer is linked to UVB exposure
- World-wide vitamin D nutrition status
- What is a measure of vitamin D status?
- 25(OH)D levels in older women
- Objective is to increase 25(OH)D in the population
- Benefits from increasing 25(OH)D levels
- Vitamin D status and intestinal calcium absorption
- Nutritional summary
- New research frontiers
- Drug development: analogs of 1alpha,25(OH)2D3
- Drug forms of 1,25(OH)2-vitamin D3 (hormone D)
- Loss of VDR results in apolecia
- Analogs of hormone D are effective for psoriasis
- 1alpha,25(OH)2D3 and the innate immune system
- Osteoporotic bone
- Vitamin D in human disease states
- Summary
- 1alpha,25(OH)2D3 plus VDR - responses
- Overall summary
- Vitamin D3 vs. 1alpha,25(OH)2-vitamin D3
- Thank you
Topics Covered
- VDR conformational ensemble
- A vitamin D receptor ensemble model
- X-ray crystal structure of the nuclear vitamin D receptor
- VDR G- and A-pocket
- Vitamin D nutrition for good health
- Sources of vitamin D
- How much vitamin D do we need?
- World-wide vitamin D nutrition status
- Vitamin D status and intestinal calcium absorption
- New research frontiers
- Drug development
- Alopecia
- Analogs of hormone D are effective for psoriasis
- hormone-D activates the innate immune system -Vitamin D in human disease states
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Norman, A. (2007, December 1). Vitamin D endocrine system: VDR binding, nutrition and drugs development [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/WVLM7224.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Anthony Norman has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Vitamin D endocrine system: VDR binding, nutrition and drugs development
A selection of talks on Metabolism & Nutrition
Hide